Author(s):
Gupta S. K., Sachan N., Chandra P., Sharma A. K.
Email(s):
shivki4u@gmail.com
DOI:
10.5958/0974-360X.2020.00775.1 
Address:
Gupta S. K.1,2*, Sachan N.2, Chandra P.2, Sharma A. K.3
1Sanskar College of Pharmacy and Research, Opp. Jindal Pipes Ltd. NH-24, Ahead Masuri Canal, Ghaziabad, Uttar Pradesh 201302 (India).
2School of Pharmaceutical Sciences, IFTM University, NH-24, Lodhipur, Moradabad, Uttar Pradesh, India.
3Pharmacy Academy, IFTM University, NH-24, Lodhipur, Moradabad, Uttar Pradesh, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 9,
Year - 2020
ABSTRACT:
Topotecan is an anti-cancer drug used against ovarian cancer. It acts by inhibiting DNA-topoisomerase-I. A simple, robust, accurate and precise assay RP-HPLC method having rapid stability indication has been developed and subsequently validated for the quantitative estimation of Topotecan in API and in solid dosage form. The method so proposed is based on quantification of drug Topotecan in reversed phase using water’s C18 column which was maintained at an ambient temperature. The selected mobile phase consist of mixture of Acetonitrile: DMF: Water (60:10:30,v/v) at pH maintained to 2.5 with O-Phosphoric acid (1 : 100,v/v). The flow rate used was 1.0ml/min and injection volume was 20ml, detected at the wavelength of 297nm. The method was validated according to ICH guideline. The method was found to be accurate, robust, reproducible and linear. The drug was exposed to variable stressed conditions and was studied using the proposed method. The results reflects That there were no interfering peaks from exicipients, impurities or degradative products generated during stress conditions. Thus the proposed method for quantifying the Topotecan is specific and can be applied in the quality control and stability study of sample as API and solid dosage form.
Cite this article:
Gupta S. K., Sachan N., Chandra P., Sharma A. K. A Robustustic Eco-Friendly Analytical Method to Quantify Topotecan in Pharmaceuticals by RP-HPLC. Research J. Pharm. and Tech 2020; 13(9):4387-4390. doi: 10.5958/0974-360X.2020.00775.1
Cite(Electronic):
Gupta S. K., Sachan N., Chandra P., Sharma A. K. A Robustustic Eco-Friendly Analytical Method to Quantify Topotecan in Pharmaceuticals by RP-HPLC. Research J. Pharm. and Tech 2020; 13(9):4387-4390. doi: 10.5958/0974-360X.2020.00775.1 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2020-13-9-63
REFERENCES:
1. Martindale, the Extra Pharmacopoeia, 31st Edition, Royal Pharmaceutical Society, 604; 1996.
2. Varanasi MB, Khan MA, Jangala VR, Teja BB. Validated reverse phase HPLC method for the determination of topotecan in pharmaceutical dosage forms. Oriental Journal of Chemistry. 2009; 25(4): 913-922.
3. Januchowski R , Sterzyńska K, Zaorska K, Sosińska P, Klejewski A, Brązert M, Nowicki M, Zabel M. Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines. Journal of Ovarian Research. 2016; 9(65).
4. Zhang L, Marrano P, Wu B, Kumar S, Thorner P, Baruchel S, Combined Antitumor Therapy with Metronomic Topotecan and Hypoxia-Activated Prodrug, Evofosfamide, in Neuroblastoma and Rhabdomyosarcoma Preclinical Models, Clinical Cancer Research. 2016; 22(11): 2697-2708.
5. Horita N, Yamamoto M, Sato T, Tsukahara T, Nagakura H, Tashiro K, Shibata Y, Watanabe H, Nagai K, Inoue M, Nakashima K, Ushio R, Shinkai M, Kudo M, Kaneko T. Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients. Sci. Rep.2015; 5, 15437.
6. Ghassemi F, Shields CL, Ghadimi H, Khodabandeh A, Roohipoor R. Combined Intravitreal Melphalan and Topotecan for Refractory or Recurrent Vitreous Seeding From Retinoblastoma JAMA Ophthalmol. 2014; 132(8): 936-941.
7. Jain A, Gulbake A, Jain A, Shilpi S, Hurkat P, Kashaw S, Jain SK. Development and Validation of the HPLC Method for Simultaneous Estimation of Paclitaxel and Topotecan. Journal of Chromatographic Science. 2014; 52(7): 697-703.
8. Saini PK, Jain CL, Singh RM, Mathur SC, Singh GN. Development and validation of a rp-ultra performance liquid chromatographic method for quantification of topotecan hydrochloride in bulk and injection dosage form. Indian Journal of Pharmaceutical Science. 2010; 72 (4): 494-497.
9. Chen J, Balthasar JP. High-performance liquid chromatographic assay for the determination of total and free topotecan in the presence and absence of anti-topotecan antibodies in mouse plasma. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2005; 816(1-2): 183-92.
10. Walter J, Zomeren LDM, Jaap HG, Nooter VK, Stoter G, Sparreboom A. Determination of topotecan in human whole blood and unwashed erythrocytes by high-performance liquid chromatography. Journal of Chromatography B, 2002; 766 (1): 99-105.
11. Hsu LC. High Performance Reverse Phase Liquid Chromatographic Method for Topotecan Trace Analysis. Journal of Liquid Chromatography and Related Technologies 1996; 19(4): 611-624.
12. L.R. Snyder, J.J. Kirkland, L.J. Glajch, Practical HPLC Method Development. 2nd ed. New York: John Wiley and Sons Inc; 709, 20, (1997).
13. Gupta SK, Kumar B, Sharma PK. Development and Validation of a RP-HPLC method for estimation of Thalidomide in solid dosage form. Asian Journal of Pharmaceutical Analysis 2013; 3(1): 17-19.
14. Gupta SK, Kumar B, Sharma PK. Study on Taste Masking of Ranitidine HCl Using Ion Exchange Resin. Asian Journal of Pharmaceutical Technology, 2013; 3(2): 60-62.
15. Gupta SK, Sachan N, Chandra P, Sharma AK. Application of RP-HPLC method for stability study and quantifying Decitabine in bulk drug and in Pharmaceutical dosage form. International Journal of Pharmaceutical Research. 2020; 12(4): 261-267.
16. International Conference on Harmonisation (ICH), Geneva 1999. Specification test procedure and acceptance criteria for new drugs substances and new drug products, International Conference of Harmonization, IFPMA.
17. ICH. Proceedings of the International Conference on Harmonisation of Technical Requirement of Registration of Pharmaceuticals for Human Use (ICH Harmonised Tripartite Guidelines). Validation of Analytical Procedures: Methodology, Q2B; 1996. Geneva, Switzerland.
18. International Conference on Harmonisation (ICH), USA 1994. Technical requirements for the Registration of Pharmaceutical for Human Use, Validation of analytical methods: definition and terminology, ICHQ2 R1.